Donor human leukocyte antigens in the circulation of liver allograft recipients

B. Chauhan, J. M. Mathew, S. Shenoy, M. W. Flye, T. Howard, T. Mohanakumar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Using a solid phase enzyme immunoassay (ELISA) with three different murine monoclonal antibodies (mAb) to HLA (human leukocyte antigens) framework determinants, circulating HLA were detected and quantitated both in normal individuals as well as liver allograft recipients. In normal individuals, the level of circulating HLA remained constant for several months of this study. The quantity of antigens present in the sera was not influenced by the collection procedures. During the immediate post-transplant period there was detectable donor HLA in the recipient's circulation; however, no correlation was noted between graft function and the large quantity of donor HLA present in the sera. Within 5 months after transplantation there was a gradual decrease in the amount of circulating HLA compared to the level seen in normal individuals. These shed donor antigens may play an active role in initiating the development of tolerance to the transplanted organ.

Original languageEnglish (US)
Pages (from-to)14-19
Number of pages6
JournalClinical Transplantation
Volume9
Issue number1
StatePublished - 1995

Keywords

  • HLA
  • Liver allograft
  • Quantitation

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Donor human leukocyte antigens in the circulation of liver allograft recipients'. Together they form a unique fingerprint.

Cite this